Norepinephrine Kabi (Noradrenaline Tartrate)

Norepinephrine Kabi acts on the adrenergic system to support circulatory function in critical care settings.

• Hypotension: restores adequate arterial pressure when conventional fluids are insufficient.
• Septic shock: counteracts vasodilatory failure to maintain perfusion of vital organs.
• Cardiac arrest: provides immediate vasoconstriction to improve coronary and cerebral blood flow during resuscitation.

• Norepinephrine Kabi is an alpha‑adrenergic agonist that stimulates vascular smooth‑muscle α1 receptors, producing potent vasoconstriction and increasing systemic vascular resistance. It also has modest β1 activity, enhancing myocardial contractility and heart rate, which together raise arterial pressure and improve organ perfusion in shock states.

Norepinephrine Kabi may cause a range of adverse reactions that clinicians monitor during infusion.

Common Side Effects

• Tachycardia: elevated heart rate due to β1 stimulation.
• Headache: result of rapid blood pressure changes.
• Anxiety or restlessness: central nervous system response.
• Peripheral ischemia: reduced blood flow to extremities.
• Extravasation injury: local tissue damage if the solution leaks from the vein.

Serious or Rare Side Effects

• Severe hypertension: excessive rise in blood pressure.
• Cardiac arrhythmias: potentially life‑threatening rhythm disturbances.
• Myocardial ischemia: reduced oxygen supply to heart muscle.
• Limb necrosis: tissue death from prolonged vasoconstriction.
• Pulmonary edema: fluid accumulation in lungs due to increased afterload.

Use of Norepinephrine Kabi requires careful monitoring and adherence to safety guidelines.

• Blood pressure monitoring: titrate infusion to maintain target MAP.
• Cardiac rhythm observation: watch for arrhythmias, especially in patients with pre‑existing heart disease.
• Volume status assessment: ensure adequate intravascular volume before initiation.
• Peripheral perfusion checks: inspect infusion sites frequently for signs of ischemia.
• Contraindications: avoid in patients with uncontrolled hypertension or pheochromocytoma.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Norepinephrine Kabi can interact with several drug classes, influencing its efficacy and safety.

Major Interactions (Avoid)

• MAO inhibitors: risk of hypertensive crisis.
• β‑blockers: may blunt β1‑mediated cardiac effects.
• Vasodilators (e.g., nitroglycerin): antagonize vasoconstrictive action.

Moderate Interactions (Monitor Closely)

• Tricyclic antidepressants: additive increase in blood pressure.
• Calcium channel blockers: potential for exaggerated hypotension if norepinephrine is weaned.
• Diuretics: may exacerbate intravascular volume depletion.